Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emily Girsch"'
Autor:
Rebecca L. Farr, Cristina Mitrea, Greg Dyson, Aliccia Bollig-Fischer, Priyanga Wijesinghe, Stanley R. Terlecky, Emily Girsch, Bin Bao, Ramzi M. Mohammad, Julie L. Boerner, Luca Marchetti
Publikováno v:
Scientific Reports
Among breast cancer patients, those diagnosed with the triple-negative breast cancer (TNBC) subtype have the worst prog-nosis. TNBC does not express estrogen receptor-alpha, progesterone receptor, or the HER2 oncogene; therefore, TNBC lacks targets f
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 27:C47-C47
Introduction: Triple-negative breast cancer (TNBC) is a molecular subtype that accounts for approximately 15-20% of invasive breast cancer diagnoses in the United States. TNBC occurs more prevalently in premenopausal African American women (AAW), and
Autor:
Emily Girsch, Bin Bao, Priyanga Wijesinghe, Cristina Mitrea, Greg Dyson, Adele Kruger, Aliccia Bollig-Fischer
Publikováno v:
Cancer Research. 78:2270-2270
Epigenetic mechanisms, such as 5-methylcytosine (5mC), are known to play a major role in breast cancer. However, the role of 5-hydroxymethylcytosine (5hmC) DNA modification remains understudied. We hypothesize that 5hmC mediates redox regulation of g
Autor:
Aliccia Bollig-Fischer, Cristina Mitrea, Gregory Dyson, Julie L. Boerner, Stan R. Terlecky, Emily Girsch, Bin Bao, Lisa Polin
Publikováno v:
Cancer Research. 77:1396-1396
Background: Among all breast cancer patients, those diagnosed with the triple-negative breast cancer (TNBC) subtype have the worst prognosis, in part attributable to the fact that TNBC lacks targets for effective molecularly-targeted therapies. The c